I don't disagree with your comment at all. However, I think the FDA's approach is "The easiest way to control unsafe drugs is to assume that anything that didn't come through approved supply channels is a fake."
It's a harsh way of approaching the problem, but you need to remember that the FDA suffers far worse when someone is harmed by a fake drug than if it seizes drugs that are safe.
It's a harsh way of approaching the problem, but you need to remember that the FDA suffers far worse when someone is harmed by a fake drug than if it seizes drugs that are safe.